A pyriform sinus cancer organ preservation strategy comprising induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil, followed by potentiated radiotherapy: a multicenter, retrospective study - Archive ouverte HAL
Journal Articles Anti-cancer Drugs Year : 2014

A pyriform sinus cancer organ preservation strategy comprising induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil, followed by potentiated radiotherapy: a multicenter, retrospective study

P. Ceruse
  • Function : Author
A. Cosmidis
  • Function : Author
A. Belot
  • Function : Author
Muriel Rabilloud
Biostatistiques santé [LBBE]
CV
C. Fuchsmann
  • Function : Author
M. Poupart
  • Function : Author
A. Ramade
  • Function : Author
S. Tartas
  • Function : Author
V. Favrel
  • Function : Author
P. Pommier
  • Function : Author
P. Zrounba
  • Function : Author
J. Fayette
  • Function : Author

Domains

Life Sciences [q-bio]

Christelle Cheval  : Connect in order to contact the contributor

https://hal.science/hal-02072969

Submitted on : Tuesday, March 19, 2019-3:19:37 PM

Last modification on : Sunday, May 19, 2024-3:09:57 AM

No file

Dates and versions

hal-02072969 , version 1 (19-03-2019)

Identifiers

Cite

P. Ceruse, A. Cosmidis, A. Belot, Muriel Rabilloud, C. Fuchsmann, et al.. A pyriform sinus cancer organ preservation strategy comprising induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil, followed by potentiated radiotherapy: a multicenter, retrospective study. Anti-cancer Drugs, 2014, 25, pp.970-5. ⟨10.1097/CAD.0000000000000126⟩. ⟨hal-02072969⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

CNRS UNIV-LYON1 BIOENVIS LBBE UDL
27 View
0 Download

Altmetric

Share

More